NFKB1 and autosomal dominant polycystic kidney disease: Furthermore, TWEAK inhibition attenuated inflammatory responses by decreasing the activation of the NF-κB pathway and indirectly reducing the recruitment of macrophages to the kidney, which are known contributors to ADPKD inflammation and fibrosis.